Augustina Isioma Ikusemoro: Is Blood Really Affordable?
Augustina Isioma Ikusemoro, Hematology and Transfusion Medicine Specialist at Sharjah Blood Transfusion and Research Center, shared a post on LinkedIn:
“In many LMICs, families must pay out of pocket for blood transfusions – often at the worst moment of their lives.
Behind every ‘unit’ of blood lies:
- Testing
- Processing
- Cold storage
- Transport
- Skilled expertise
Safe blood saves lives — but it isn’t cheap to produce.
The real tragedy?
- People don’t die because blood doesn’t exist.
- They die because they can’t afford it.
No woman should bleed to death in childbirth.
No child should die of treatable anemia.
No trauma victim should be denied transfusion because of cost.
- Safe blood must be treated as a public health necessity — not a market commodity.
Universal Health Coverage is incomplete without universal access to safe blood.
The Way Forward
Countries that have transformed blood safety share common solutions:
- Strong centralized national blood services
- Government financing and policy commitment
- Universal access models (blood as a public good)
- Investment in infrastructure and workforce
- Robust donor recruitment systems
- Integration into national health insurance schemes
Safe blood systems do not emerge by chance — they are built through leadership, policy, and sustained investment.
- We must stop asking whether blood is expensive.
- We must start asking why patients are the ones paying the price.
Blood is not just a product.
It is a critical component of health system resilience.
And in emergencies, it is the difference between life and death.
If your country still relies heavily on out-of-pocket payments for blood transfusion, what reforms do you believe are most urgent?
Let’s move this conversation from awareness to policy to action.”
Stay updated with Hemostasis Today.
-
Apr 28, 2026, 16:26Andrew Zapfel: The ASH’s Consortium on Newborn Screening in Africa Brought Together Over 40 People From 10 Countries
-
Apr 28, 2026, 16:22Beth Fernandes: Bringing Alaska’s First Civilian Medevac Whole Blood Program To Life
-
Apr 28, 2026, 15:47Dianne E. van der Wal: How Rat and Human Platelet Vesicles Are Different
-
Apr 28, 2026, 15:14Elaheh Mansouri: Platelet Clumping Is a Common Pre-Analytical and Analytical Challenge in Haematology
-
Apr 28, 2026, 15:11Hans Vrielink: Honoured to Receive the Cohn the Laval Award at the ASFA/WAA
-
Apr 28, 2026, 15:07Stan Van Boeckel: Pitfalls in Early Drug Discovery
-
Apr 28, 2026, 15:02Stephani Carolina Salvatierra Moreno: Our Study on Microneedling and PRP Has Been Published
-
Apr 28, 2026, 14:57Steven Heylen: Hydrolyzed Collagen Injections for Knee Osteoarthritis as a New Treatment Option
-
Apr 28, 2026, 14:22Heghine Khachatryan: Regarding Coagulation Factor Dynamics During Pregnancy in Hemophilia B Carriers